The global single cell sequencing market is projected to grow at a 15% CAGR through 2035, reaching an estimated value of $1.38 billion in 2026. Growth is fueled by advances in genomics, reduced sequencing costs, and increased use in drug discovery, diagnostics, and precision medicine. North America leads the market with about 50% share, supported by strong research infrastructure and funding. Challenges remain in data processing and workflow costs, but ongoing innovations and partnerships are expected to expand adoption across academic, pharmaceutical, and clinical sectors.
The single cell sequencing market is forecasted to grow at a 15% CAGR through 2035, reaching $1.38 billion by 2026. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 20, 2026 15:51 WIB: out of 150 priced US health stocks, 80 rose and 61 fell today. Notable movers include XRAY (DENTSPLY SIRONA Inc) at USD 8.84 with a +4.99% change and a typical hold time of 73 days, ENVB (Enveric Biosciences Inc) at USD 1.34 down -4.96% with 100% sell order activity and a 14-day hold time, and MESO (Mesoblast Limited) at USD 12.46 up +4.27% with a 16-day hold time.
The global flue gas desulfurization (FGD) system market is expected to increase from $23.6 billion in 2026 to $31.7 billion by 2031, driven by stricter sulfur dioxide emission regulations and ongoing coal power use in developing countries. Growth is ...
The global API 6D ball valve market is projected to grow from $1.20 billion in 2025 to $1.61 billion by 2031, at a 5% compound annual growth rate. Growth is fueled by investments in oil and gas infrastructure, LNG capacity, and refining operations. N...
VINCI's subsidiary Cobra IS secured a €165 million contract to build the cooling system for a massive data center campus in the Iberian Peninsula. The project includes installing mechanical, electrical, and plumbing equipment for 126 air cooling unit...
VINCI's subsidiary Cobra IS secured a €165 million contract to construct a cooling plant for a major data center campus in the Iberian Peninsula. The project involves installing mechanical, electrical, and plumbing systems for 126 dry coolers, which ...
Basilea Pharmaceutica announced new clinical and activity data for its antifungal drugs fosmanogepix and isavuconazole, as well as the antibiotic ceftobiprole, to be presented at IDWeek 2026 in Washington D.C. Highlights include pediatric data from f...
